Design of a potential Sema4A-based multi-epitope vaccine to combat triple-negative breast cancer: an immunoinformatic approach
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s12032-023-01970-6.pdf
Reference56 articles.
1. Lesions L, Geyer FC, Pareja F, Weigelt B, Rakha E, Ellis IO, Schnitt SJ, Reis-Filho JS. The spectrum of triple-negative breast disease. Am J Pathol. 2017;187:2139–51.
2. Liu Z, Li M, Jiang Z. A comprehensive immunologic portrait of triple-negative breast cancer. Transl Oncol. 2018;11:311–29.
3. Corti C, Giachetti PPMB, Eggermont AMM, Delaloge S, Curigliano G. Therapeutic vaccines for breast cancer: has the time finally come? Eur J Cancer. 2022;160:150–74.
4. Katz H, Alsharedi M. Immunotherapy in triple-negative breast cancer. Med Oncol. 2018;35:1–9.
5. Abdou Y, Goudarzi A, Yu JX, Upadhaya S, Vincent B, Carey LA. Immunotherapy in triple negative breast cancer: beyond checkpoint inhibitors. Npj Breast Cancer. 2022;8(1):121.
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. An immunoinformatics approach for a potential NY-ESO-1 and WT1 based multi-epitope vaccine designing against triple-negative breast cancer;Heliyon;2024-09
2. Tackling suppressive cancer microenvironment by NARF-derived immune modulatory vaccine and its validation using simulation strategies;Frontiers in Physics;2024-02-22
3. Novel immunotherapies for breast cancer: Focus on 2023 findings;International Immunopharmacology;2024-02
4. Advancements and hurdles in the development of a vaccine for triple-negative breast cancer: A comprehensive review of multi-omics and immunomics strategies;Life Sciences;2024-01
5. Semaphorins and Their Roles in Breast Cancer: Implications for Therapy Resistance;International Journal of Molecular Sciences;2023-08-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3